Home » Newsletters » BioWorld Science

BioWorld Science

March 12, 1998

View Archived Issues

Amrad: HY 1997/98 highlights

P&U scientists disclose new MMP inhibitors for connective tissue diseases

Advanced Tissue Sciences: year-end 1997 highlights

Amylin: FY 1997 highlights

Novopharm Biotech: FY 1997 highlights

Cubist's daptomycin shows activity against VISA bacterial strains

AltaRex: Q4 and year-end 1997 highlights

DynaGen allowed U.S. patent for ImmuDyn HIV/AIDS use

U.S. patent awarded for Sertoli cell transplants

Rhone-Poulenc Rorer synthesizes and evaluates new TNF/cAMP PDE inhibitors

New antitumor and immunosuppressive compounds in development at Klinge

Cidofovir demonstrates anti-poxvirus activity in primates

Antithrombotics developed at Warner-Lambert

Novel immunomodulatory agents described by Takeda

Cephalon reports K-252a derivatives for neurology indications

Vasopressin antagonists for treating CHF

Macrolactine M described by Ocean Biotechnology

Novel gastrointestinal agents in early development at Dainippon

Merck investigates antidiabetic/antiobesity agents

SKB azaspiranes exert topical antiinflammatory effects via a novel mechanism of action

FDA approves three-day treatment option for bacterial vaginosis

New testosterone replacement patch launched in U.S.

Isis and Genelabs Technologies announce novel collaborative R&D effort

Chrysalis and Pfizer embark on genomics research collaboration

Sch-40832: a novel thiostrepton antimicrobial agent

Oxandrin approved in Russia

Discovery Laboratories to merge with Acute Therapeutics subsidiary

R.P. Scherer reveals the identity of two more pipeline products

Gemzar approved in Canada

European academics collaborate on R&D of novel NNRTIs

Interim safety data reported for Procysteine

Bristol-Myers Squibb and UT Austin announce cancer collaboration